<DOC>
	<DOCNO>NCT02611596</DOCNO>
	<brief_summary>The purpose investigation compare subject high risk silent myocardial ischemia placebo group subject high risk silent myocardial ischemia ranolazine group determine ranolazine use treatment decrease silent myocardial ischemia ( SMI ) . Subjects high risk silent myocardial ischemia define protocol diabetic stable ischemic heart disease . This study look impact ranolazine treatment biomarkers show highly associate increase risk morbidity mortality relation SMI . If hypothesis correct , study conduct determine treatment ranolazine impact long-term outcome hospitalization , myocardial infarction , congestive heart failure sudden cardiac death .</brief_summary>
	<brief_title>Does Ranolazine Decrease Biomarkers Myocardial Damage Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Subjects risk silent myocardial ischemia define : Stable ischemic heart disease define : Obstruction least one epicardial vessel &gt; 50 percent invasive noninvasive coronary angiography , Evidence ischemia infarct SPECT imaging , History myocardial infarction &gt; 3 month ago , Stent placement ( PCI ) &gt; 3 month ago , Coronary artery bypass grafting ( CABG ) &gt; 3 month ago AND Type 2 diabetic define : HgbA1C ≥ 6.5 percent , Fasting Blood Glucose &gt; 125 mg/dL two blood draw , Random Blood Glucose ≥ 200 mg/dL single blood draw , Previous diagnosis type 2 diabetes list subject 's medical record AND On Optimal Medical Therapy define ALL following time enrollment : Beta Blocker Aspirin Statin AND Females &lt; 60 free menstruation 2 year ( menopause diagnose ) document history hysterectomy must willing use least one form birth control ( include abstinence option ) duration study . If condoms method chosen , strongly urge use second form birth control addition condom . AND Screening Criteria meet : • h cTnT &gt; 0.014 ng/mL Percutaneous intervention/stent placement past 3 month Coronary artery bypass graft past 3 month Treatment ranolazine past 12 month Significant lung disease , COPD use supplemental oxygen Cirrhosis Estimated Glomerular Filtration Rate ( GFR ) &lt; 30 Subject take strong CYP3A inhibitor ( ketoconazole , itraconazole , clarithryomycin , nefazodone , nelfinavir , ritonavir , indinavir saquinavir ) Subject take strong CYP3A inducer ( rifampin , rifabutin , rifapentin , phenobarbital , phenytoin , carbamazepine , St. John 's wort ) Subjects take Pgp Inhibitors ( cyclosporine ) Subject take concurrent simvastatin &gt; 20 mg/day Subject take metformin &gt; 1700 mg/day NYHA Class 3 4 Heart Failure ( severe ) Canadian Cardiovascular Society Grade 4 Angina Unstable angina define new angina occur minimal exercise rest OR significant increase angina severity ( ≥ 2 CCS grade ) occur minimal exertion , high clinical suspicion acute coronary syndrome . Planned PCI Cardiac Surgery Pregnant females female try become pregnant Breastfeeding female Subjects young age 30 old age 85 Lactose Intolerance ( placebo lactose monohydrate ) Lactose/Milk allergy ( placebo lactose monohydrate ) QTc &gt; 500 msec</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>